A Lifetime Achievement in Bioengineering: Professor Shu Chien. by Weinbaum, Sheldon et al.
UC San Diego
UC San Diego Previously Published Works
Title
A Lifetime Achievement in Bioengineering: Professor Shu Chien.
Permalink
https://escholarship.org/uc/item/9sb2346c
Journal
Annals of biomedical engineering, 47(11)
ISSN
0090-6964
Authors
Weinbaum, Sheldon
Li, Yi-Shuan Julie
Schmid-Schönbein, Geert W
Publication Date
2019-11-01
DOI
10.1007/s10439-019-02390-2
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Editorial
A Lifetime Achievement in Bioengineering: Professor Shu Chien
Any historian who looks at the development of
Bioengineering as an emerging engineering discipline in
the twentieth and twenty-ﬁrst Century, will recognize
Shu Chien as one of the cornerstones and foremost
matchmakers who facilitated the marriage between
engineering and medicine. Being trained in Medical
School in Taiwan, with a PhD Degree in cardiovas-
cular physiology at Columbia University under the
mentorship of Magnus I. Gregerson, Shu Chien
exhibited an extraordinary ability to pursue interdis-
ciplinary research opportunities for engineering. At a
time when the engineering approach to most medical
problems was unexplored, Shu’s inspiring enthusiasm
combined with his superb diplomat skills served to
build the bridges that allowed the growth of a new ﬁeld
of engineering in medicine. Shu naturally surrounded
himself with engineering and life sciences investigators
and facilitated their eﬀective collaboration long before
this practice was established. He was a key protagonist
in creating bioengineering as a new discipline.
Chien’s early work focused on rheological proper-
ties of blood. He was the founding director of the
Laboratory for Hemorheology at Columbia Univer-
sity, where he developed a major interest in the mea-
surement of the biophysical properties, and especially
the non-Newtonian and viscoelastic properties of
blood. His team carried out some of the most detailed
measurements of apparent viscosity and analyzed the
mechanisms for blood’s non-Newtonian properties due
to red cell deformability and aggregation.5 During a
sabbatical at the University of Gothenburg with Pro-
fessor P.-I. Bra˚nemark, Shu was introduced to Pro-
fessor Richard Skalak, Professor of Mechanical
Engineering and later the Director of the Bioengi-
neering Institute at Columbia University. They saw in
Bra˚nemark’s laboratory the remarkable deformation
of red cells in human capillaries and recognized the
need to develop a description of the biophysical
properties of the red cell membrane. They started a
collaboration and soon were surrounded by an
enthusiastic group of biomedical engineers that tested
the mechanical properties of single cells with tools like
micropipettes. Shu directed the systematic application
of engineering methods with well-deﬁned mechanical
stresses in combination with measurements of the red
cell membrane shape.
They lead eventually to
the ﬁrst constitutive law
for red cell membranes
deformation with Ri-
chard Skalak.19 This
constitutive law has
become the standard in
cell membrane mechan-
ics and served to predict
all types of red cell
behavior, like the para-
chute shape in single cell
ﬁle capillaries, in passing
through narrow pores,
deformation in a red cell
rouleaux, during mem-
brane tank treading and other applications. The work
also served to establish a viscoelastic model of the red
cell membrane3 and was the basis for reﬁnements that
allow more and more detailed engineering analysis of
motions and interactions of red blood cells.
As a medical doctor, Chien focused on the impor-
tance of applying this newly gained insight to analyze
blood circulation in patients. He provided fundamen-
tal assessments of rheological properties of blood in
sickle cell patients4 and other diseases.
As the understanding of red cell rheology was pro-
gressing, Shu Chien’s team added leukocytes to the
analysis of blood rheology. This pioneering step
brought to light the diﬀerences in the biophysical
properties of circulating leukocytes and red cells and
opened new ways of looking at leukocytes in circula-
tion, especially microcirculation. Measurements of the
comparatively large size, unique morphology and high
stiﬀness of leukocytes16 compared to red cells provided
the background for discovery of unique hydrodynamic
interactions between red cell and leucocytes in single
ﬁle capillaries. They are the precondition for allowing
leukocytes to start rolling on the endothelium as well
as for their adhesion to its membrane.17 The team also
discovered the surprising spontaneous activation of
circulating leukocytes in patients that leads to the
entrapment of leukocytes in microvessels and even
obstruction of capillaries. The work sparked a long-
Shu Chien
Annals of Biomedical Engineering, Vol. 47, No. 11, November 2019 ( 2019) pp. 2147–2150
https://doi.org/10.1007/s10439-019-02390-2
BIOMEDICAL
ENGINEERING 
SOCIETY
0090-6964/19/1100-2147/0  2019 The Author(s)
2147
term search for the origin of spontaneous leukocyte
activation in patients by Schmid-Scho¨nbein.
Shu saw the need to establish a research direction
which looked at blood rheology entirely in the living
circulation. With the onset of techniques to measure
pressure, ﬂow rates, hematocrit in vessels of the
microcirculation he embarked with Herbert Lipowsky
and his long-term colleague, Shunichi Usami, on a
program to study blood rheology in living blood ves-
sels.14 These studies brought to light that basic prin-
ciples in blood rheology established by in vitro studies
are also seen in vivo, but that there are also features
unique to the in vivo environment not reproduced by
in vitro studies, especially in pathophysiological con-
ditions. The ﬁrst measurements of apparent viscosity in
vessels of the microcirculation down to the size of
individual capillaries were made.
Initiated through a fortunate meeting with Shelly
Weinbaum of The City College of New York, facili-
tated by YC Fung in 1969, Shu developed an interest in
endothelial transport aspects of arterial disease. In the
early 1970’s researchers became interested in the ﬂuid
dynamic aspects of arterial disease and in particular
the role of ﬂuid shear stress in endothelial permeabil-
ity. The initial discussion was whether early lesions
formed in the high or low shear regions of the major
arteries. Permeability was measured using ﬂuorescently
labeled tracers and it was clearly demonstrated that
low shear regions had higher permeability. The central
mystery was how a molecule as large as LDL (22 nm)
could cross the endothelial lining when there were no
obvious pores for a molecule of this size since the clefts
between the endothelial cells (ECs) were signiﬁcantly
smaller even where there were breaks in the tight
junction strands that held the cells together. Initially it
was widely believed that the pore was open vesicles
which decorated the luminal surface. As proposed by
Professor George Palade, then at Yale University, the
vesicles could detach and migrate by Brownian motion
to the opposite membrane of the endothelial cells and
thus serve a ferry boat function. In 1984 Shu Chien
and Anne Baldwin reported critical experiments with
cationized ferritin which suggested that this
transendothelial transport does not occur.2 Decades
later the vesicles attached to the endothelial cell
membrane were shown to serve as ﬂuid shear-stress
shelters for membrane receptors.18
In 1985 the Chien–Weinbaum team proposed a new
paradigm for transendothelial LDL transport, namely
that the leakage was caused by endothelial cell turn-
over during the death and sloughing oﬀ of dying cells
and replacement by neighboring healthy cells during
cell division, mitosis.23 This was hypothesized to be a
rare occurrence and thus very difﬁcult to observe. Low
shear regions would have greater cell death than high
shear regions with unidirectional ﬂow. A theoretical
model was developed to predict the quantitative fea-
sibility of the concept and this model led to an NSF
‘‘Special Creativity Award’’ to design and perform a
validating experiment. By observing the entire surface
of a rat aorta with 500,000 endothelial cells one was
able to show that only one cell in several thousand on
average was undergoing cell turnover at a given time
and that this rate of turnover differed in low and high
ﬂuid shear regions around ﬂow branches.13
As a follow up to these experiments, Chien and
Weinbaum developed both a theoretical model and
experiments to examine at the cellular level the growth
of LDL leakage spots surrounding cells in turnover,
the spread of tracer in the arterial intima around these
leakage sites and the role of fenestral pores in the
underlying internal elastic lamina.10 David Rums-
chitzki, and Kung Ming Jan were also key contribu-
tors. Chien and Weinbaum continued their
collaboration for nearly 30 years. Their ﬁnal paper25
explored the rolling of leukocytes on the endothelial
glycocalyx and the penetration of leukocyte microvilli
in the rolling process.
In the late 1970s Shu saw the next major opportu-
nity to deepen the understanding of the cardiovascular
system by incorporating molecular biology into engi-
neering analysis of living systems. He committed to the
integrated research of the biochemical and mechanical
regulations in cardiovascular systems in health and
diseases. The line of research systematically investi-
gated the molecules, signaling, the processes of tran-
scription and translation, epigenetics regulations under
the inﬂuence of mechanical stresses encountered in the
circulation. It forecast the advancement of vascular cell
biology, tissue engineering, and systems biology. The
approaches contributed to the advancement of
mechanobiology, physiology and tissue engineering.
In 1988, after 31 years as a Professor at Columbia,
Shu moved with Richard Skalak, Shunichi Usami,
Paul and Amy Sung to the University of California
San Diego UCSD and joined B.W. Zweifach, Y.C.
Fung, and M. Intaglietta, who had established a bio-
engineering academic program. In 31 years at UCSD,
Shu led his team and worked with collaborators
globally to study the hemodynamic regulation of vas-
cular biology. He systematically investigated the cel-
lular events in biochemical and mechanical
environments.
The focal nature of the arterial lesion demonstrates
the impact of mechanical environment on the patho-
physiological process in the arterial tree. The lesion
prone area possesses the disturbed blood ﬂow pattern,
whereas the lesion protective area experiences a steady
laminar ﬂow. As already recognized, the lifetime of
endothelial cells on the inner lining of blood vessels
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depends greatly on their local ﬂow environment. Shu’s
studies focused on how they respond to diﬀerent blood
ﬂow patterns to modulate their gene expression, phe-
notypical changes, as well as their communications
with other vascular cells, which in turn lead to the
modulation of vascular homeostasis.6 Shu investigated
the mechanosensing mechanisms (including cell surface
integrins, receptor tyrosine kinases, G protein recep-
tors, ion channels, as well as cell membrane struc-
tures),12 cell mechanics (including the dynamics of
focal adhesion sites, cellular junction, and cytoskele-
ton),26 mechanotransduction cascades (including Rho,
AMPK, PI3 K, NFkB, and MAKP, pathways), tran-
scription machinery (including transcription factors),22
and regulation (including mRNAs, microRNAs, and
long-non-coding RNAs),1,15,20 as well as epigenetic
regulations (including DNA and histone modiﬁca-
tions).8,27 Shu not only mastered the conventional
methodologies for comprehensive studies, but also
pioneered the state-of-art technologies to investigate
the mechanophysiology in the cardiovascular system.
With collaborations, Shu employed the ﬂuorescence
resonance energy transfer {FRET} technology to
construct biosensors monitoring cellular events with
high temporal and spatial resolution to elucidate the
sequences and prorogation of mechanotransduction in
single living cells in real time.21
Shu was not only a leading contributor to the
advancement of current knowledge about cellular
mechanotransduction and regulation in the cardio-
vascular system, he also was a leader in the develop-
ment of novel tools for treatment of disease. With
colleagues, Shu developed a platelet-coated-nanopar-
ticle technology to carry the target to the injured site in
the vessels for high eﬃcacy treatment. Furthermore,
Shu extended the knowledge gained in cardiovascular
studies to multidisciplinary ﬁelds, with the best exam-
ple being stem cell research. With his colleagues he
developed the platform to investigate the eﬀects of
diﬀerent microenvironments (including substrate
composition, rigidity, and topology) on stem cell re-
newal and diﬀerentiation.7,9,24
His rich and pioneering record of scientiﬁc
achievements is summarized in more than 617 peer
reviewed scientiﬁc reports, a small selection of which is
listed below. The names of his many collaborators are
in these reports and in a Festschrift on the occasion of
his 80th Birthday.11 Shu received more than 30 research
awards, many from professional engineering societies
including the Pierre Galletti Award from the American
Institute of Medical and Biological Engineering
(AIMBE) in 2004 and two Melville Medals from the
ASME, the only person with this distinction. Shu was
elected to the National Academy of Engineering in
1997 and received their Founders Award in 2006. In
2005 he became a member of all three US National
Academies, NAE, NAS and NAM at a time when
there were only six other living individuals with this
honor. Among many other honors, he received in 2012
the National Medal of Science by President Obama.
Besides his scientiﬁc contributions he made major
contributions to the developing infrastructure of bio-
engineering in the USA and world-wide, serving as
Founding Chair of the Department of Bioengineering
at UCSD, the UCSD Institute of Engineering in
Medicine, and the California Institute for Bioengi-
neering. He was President of BMES and of AIMBE,
facilitating the creation of the National Institute of
Biomedical Imaging and Bioengineering which was
signed into law by President Clinton on December 29,
2000.
Professor Shu Chien will retire in October 2019. On
behalf of colleagues and friends around the world we
salute him with the best wishes for the next stage of his
life. We thank him for his leadership and a life-time of
friendship.
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